Form 3 - Initial statement of beneficial ownership of securities:
SEC Accession No. 0000950103-24-000070
Filing Date
2024-01-02
Accepted
2024-01-02 19:58:50
Documents
2
Period of Report
2024-01-02

Document Format Files

Seq Description Document Type Size
1 FORM 3 dp204633_3-kallebo.html 3  
1 FORM 3 dp204633_3-kallebo.xml 3 3988
2 EXHIBIT 24 dp204633_ex2400.htm EX-24 8039
  Complete submission text file 0000950103-24-000070.txt   13515
Mailing Address BIOPOLE ROUTE DE LA CORNICHE 3B EPALINGES V8 1066
Business Address BIOPOLE ROUTE DE LA CORNICHE 3B EPALINGES V8 1066 41 21 653 02 00
ADC Therapeutics SA (Issuer) CIK: 0001771910 (see all company filings)

EIN.: 000000000 | State of Incorp.: V8 | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)

Mailing Address C/O ADC THERAPEUTICS SA BIOPOLE ROUTE DE LA COMICHE 3B EPALINGES V8 1066
Business Address
Kallebo Lisa Michelle (Reporting) CIK: 0002000724 (see all company filings)

Type: 3 | Act: 34 | File No.: 001-39071 | Film No.: 24504069